Why Amphastar Pharmaceuticals (AMPH) Stock Is Trading Lower Today
Amphastar Pharmaceuticals (NASDAQ:AMPH) executives said the company is taking steps to address rebate and discounting pressure on BAQSIMI while maintaining its full-year revenue outlook, according to remarks...
The 5 Most Interesting Analyst Questions From Amphastar Pharmaceuticals’s Q1 Earnings Call
Q1 Earnings Roundup: Amphastar Pharmaceuticals (NASDAQ:AMPH) And The Rest Of The Pharmaceuticals Segment
Amphastar Pharmaceuticals (NASDAQ:AMPH) reported first-quarter 2026 net revenues of approximately $171.2 million, up slightly from $170.5 million in the prior-year period, as recently launched products...
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q1 CY2026 Sales Expectations, Stock Drops
Barchart Research What to Expect from AMPH Earnings AMPH Generated May 6, 2026 Current Price $23.90 EPS Estimate $$0.62 Consensus Rating Hold Average Move 9.09% Amphastar's Pipeline Has Carried the Story...
Amphastar Pharmaceuticals (AMPH) To Report Earnings Tomorrow: Here Is What To Expect
1 Cash-Producing Stock for Long-Term Investors and 2 We Turn Down